Richmond, Feb. 05, 2024 (GLOBE NEWSWIRE) -- According to a research report "Cell Culture Media Market”, by Type (Serum-free Media {HEK293 Media, Insect Media, Hybridoma Media, CHO Media, Others}, Specialty Media {T Cell & Immunotherapy Media, MDCK Media, Vero Media, Others}, Stem Cell Media {hPSC Media, MSC Media, Others}, Classical Media, Others), Form (Liquid Media, Semi-solid, and Solid Media), Application (Health and Disease, Drug Development and Drug Testing, Virology and Vaccine Production, Tissue Regeneration and Transplantation, Genetic Engineering, and Gene Therapy, Monoclonal antibodies, Cancer Research, Other), End User (Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Laboratories, Research & Academic Institutes, Others) and Region - Global Forecast to 2030.
Global Cell Culture Media Market Report Scope:
| Report | Details |
| Market size value in 2023 | USD 3.3 Billion |
| Market size value in 2030 | USD 5.6 Billion |
| CAGR (2023-2030) | 6.8% |
| Forecast Period | 2023–2030 |
| Historic Data | 2019 |
| Forecast Units | Value (USD Million/USD Billion) |
| Segments Covered | Type, Application, End User and Region |
| Geographies Covered | North America, Europe, Asia Pacific, and RoW |
| |
| |
| Sample of Companies Covered |
|
| |
|
Download the Sample - https://www.marketdigits.com/request/sample/3943
TOC Covers in Depth & Breath on Cell Culture Media Market
170 - Market Data Tables
65 - List of Figures
225 – Pages
The report includes Vendor Assessment (Company Profiles, Market Positioning, Strategies, Recent Developments, Capabilities & Product Offerings / Mapping), Technology Assessment (Developments & Economic Impact), Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional FootPrint by MarketDigits.
Market Overview
The global cell culture media market occupies an essential role in the healthcare industry. The cell culture media market is an important element in the biopharmaceutical and biotechnology sectors, serving a key role in producing therapeutic proteins, vaccines, and other biopharmaceutical products. Essentially, cell culture media is a mix of nutrients and growth factors that create an optimal environment for cells to grow and be maintained in a lab. The market has seen substantial growth due to the increasing demand for biopharmaceuticals, a rise in cell-based therapies, and a growing need for advanced cell culture techniques in drug discovery. Driven by factors like the expansion of the biopharmaceutical industry and increased research and development, the cell culture media market is growing. This growth is further driven by a focus on personalized medicine, regenerative therapies, and the introduction of innovative technologies like 3D cell culture and perfusion systems. While North America and Europe have traditionally dominated the market, the globalization of the biopharmaceutical industry and investments in healthcare infrastructure are shifting the growth dynamics to Asia-Pacific and Latin America. In essence, the cell culture media market is dynamic, shaped by technological advancements, strategic collaborations, and a growing importance on improving bioprocessing efficiency.
Major Vendors in the Global Cell Culture Media Market:
- Becton Dickinson and Company
- Bio-Rad Laboratories, Inc.
- Caisson Laboratories Inc.
- Cell Culture Technologies LLC
- Corning
- Cytiva
- FORTUNE Media IP
- FUJIFILM
- Hi Media Laboratories Pvt. Ltd.
- Lonza Group AG
- Merck KGaA
- PL BioScience GmbH
- Pricella Biotchnology Co., Ltd
- Thermo Fisher Scientific, Inc.
Request for Discount @ https://www.marketdigits.com/request/discount/3943
The Expansion Of The Biopharmaceutical Sector
One of the primary drivers for the global cell culture media market is the expansion of the biopharmaceutical sector. The expansion of the biopharmaceutical sector has been an essential driver for the growing Cell Culture Media Market. The rising demand for biopharmaceutical products demands the parallel development of cell culture media to support the efficient production of biologics. The biopharmaceutical industry, encompassing domains such as vaccine development, monoclonal antibody production, and gene therapy, relies extensively on cell culture technologies for cultivating cells in therapeutic contexts. This heightened biopharmaceutical activity has generated a corresponding need for advanced and specialized cell culture media formulations capable of sustaining optimal cell growth and productivity in vitro. Consequently, the market is undergoing a prominent shift towards more advanced and personalized media formulations, specifically designed for distinct cell lines and applications. The growing emphasis on personalized medicine and regenerative therapies further amplifies the demand for innovative cell culture media formulations, offering a beneficial landscape for market expansion.
Market Dynamics
Drivers:
- The Expansion Of The Biopharmaceutical Sector
- A Heightened Focus On Regenerative Therapies
- Rising Incidence Of Chronic Diseases
- Increasing Healthcare Investments
Opportunities:
- Growing Research And Development Activities In The Biopharmaceutical
- Rising Demand For Personalized Medicine
- Increasing Advancements In Cell-Based Therapies
- Continuous Advancements In Technologies Such As 3D Cell Culture
Increasing Advancements In Cell-Based Therapies
The cell culture media market is presented with substantial opportunities due to the increasing advancements in cell-based therapies. The domain of cell-based therapies, spanning stem cell therapies and immunotherapies, has witnessed remarkable advances in recent years. These therapies, demonstrating significant potential in treating diverse ailments such as cancer, autoimmune disorders, and degenerative conditions, are transitioning from experimental to clinical applications. In this context, the imperative for advanced and specialized cell culture media becomes dominant, as personalized formulations play a critical role in maintaining the viability, functionality, and safety of therapeutic cells during the manufacturing process. The opportunity for cell culture media providers lies in the development of advanced formulations adept at supporting the unique requisites of diverse cell-based therapies, ensuring consistent and high-quality production. The convergence of cell-based therapies and sophisticated cell culture media gives a promising avenue for market participants to contribute to the advancement of regenerative medicine and personalized healthcare.
North America dominates the market for Cell Culture Media Market.
North America stands out as the dominating region in the global cell culture media market, with the United States leading in consumption and market share. The cell culture media market has grown significantly, due to the strong biopharmaceutical industry and extensive research and development efforts. Major pharmaceutical companies, academic institutions, and research centers in the region drive the demand for advanced cell culture media formulations. Additionally, supportive regulations and a solid healthcare infrastructure contribute to the market's expansion. The focus on personalized medicine and ongoing technological innovations, such as 3D cell culture and perfusion systems, further boost the need for specialized cell culture media.
Asia-Pacific is emerging as a key player with substantial growth potential in the cell culture media market. The cell culture media market is on the rise due to the global reach of the biopharmaceutical industry and increased investments in healthcare infrastructure. The region has become a central hub for collaborative research and outsourcing, creating a favorable environment for the cell culture media market. Growing biopharmaceutical activities, especially in countries like China and India, play a crucial role in market growth. The rising prevalence of chronic diseases and the heightened importance of regenerative therapies in Asia-Pacific contribute to the demand for advanced cell culture media, positioning the region as a key player in the global market.
Inquire Before Buying: https://www.marketdigits.com/request/enquiry-before-buying/3943
The Serum-free Media Segments is anticipated to hold the Largest Market Share during the Forecast Period
In the global cell culture media market, the type segment comprises various categories such as Serum-free Media, Specialty Media, Vero Media, Stem Cell Media, Classical Media, and Others. The Serum-free Media segment within the cell culture media market is a key component, marking a significant departure from traditional cell culture practices. This segment has gained prominence due to the numerous advantages it offers over media formulations containing animal-derived serum. Serum-free media eliminates the associated risks, such as variability, contamination, and the potential transmission of adventitious agents. The heightened demand for controlled and reproducible cell culture conditions in biopharmaceutical manufacturing has propelled the widespread adoption of serum-free media. These formulations provide a well-defined environment, ensuring greater consistency in cell culture performance and downstream processes. Serum-free media are versatile, catering to the diverse requirements of various cell types, including mammalian and insect cells, thereby supporting applications from vaccine production to cell-based therapies. With the continuous expansion of the biopharmaceutical sector, the Serum-free Media segment is poised for substantial growth.
Major Segmentations Are Distributed as follows:
- By Type
- Serum-free Media
- HEK293 Media
- Insect Media
- Hybridoma Media
- CHO Media
- Others
- Specialty Media
- T Cell & Immunotherapy Media
- MDCK Media
- Vero Media
- Others
- Stem Cell Media
- hPSC Media
- MSC Media
- Others
- Classical Media
- Others
- Serum-free Media
- By Form
- Liquid Media
- Semi-solid
- Solid Media
- By Application
- Health and Disease
- Drug Development and Drug Testing
- Virology and Vaccine Production
- Tissue Regeneration and Transplantation
- Genetic Engineering and Gene Therapy
- Monoclonal antibodies
- Cancer Research
- Others
- End User
- Pharmaceutical & Biotechnology Companies
- Hospitals & Diagnostic Laboratories
- Research & Academic Institutes
- Others
- By Region
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa
Elevate Your Business Strategy! Purchase the Report for Market-Driven Insights @ https://www.marketdigits.com/checkout/3943?lic=s
Browse Similar Reports:
Stem Cells Market 2030 By Type, Distribution Channel, End-user and Region - Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional Footprints by MarketDigits
Single-cell Omics Market 2030 By Product Type (Single-cell genomics, Single-cell transcriptomics, Single-cell proteomics, Single-cell metabolomics), Application (Oncology, Cell biology, Neurology, Immunology, Other applications), End-user and Region - Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional Footprints by MarketDigits
3D Cell Culture Market 2030 By Type, Distribution Channel, End-user and Region - Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional Footprints by MarketDigits
About MarketDigits:
MarketDigits is one of the leading business research and consulting companies that helps clients to tap new and emerging opportunities and revenue areas, thereby assisting them in operational and strategic decision-making. We at MarketDigits believe that a market is a small place and an interface between the supplier and the consumer, thus our focus remains mainly on business research that includes the entire value chain and not only the markets.
We offer services that are most relevant and beneficial to the users, which help businesses to sustain themselves in this competitive market. Our detailed and in-depth analysis of the markets catering to strategic, tactical, and operational data analysis & reporting needs of various industries utilize advanced technology so that our clients get better insights into the markets and identify lucrative opportunities and areas of incremental revenues.
Contact Us:
MarketDigits
1248 CarMia Way Richmond,
VA 23235,
United States.
USA: +1 847 450 0808
Email: sales@marketdigits.com
Web: https://www.marketdigits.com
Follow Us on: | Twitter | LinkedIn |
